Eli Lilly
LLY
#13
Rank
HK$7.263 T
Marketcap
HK$8,103
Share price
1.27%
Change (1 day)
27.08%
Change (1 year)

With over 33,000 employees worldwide, production plants in 13 countries and annual sales of over $22 billion worldwide, Eli Lilly and Company is one of the largest pharmaceutical companies in the world. It was founded in Indianapolis in 1876 by the pharmacologist, officer and entrepreneur Eli Lilly.

Eli Lilly (LLY) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$711.61 Billion

According to Eli Lilly's latest financial reports the company's total liabilities are HK$711.61 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eli Lilly - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$500.30 B20.54%
2023-12-31HK$415.04 B37.21%
2022-12-31HK$302.48 B-2.17%
2021-12-31HK$309.18 B-2.27%
2020-12-31HK$316.35 B11.02%
2019-12-31HK$284.94 B10.27%
2018-12-31HK$258.41 B-0.71%
2017-12-31HK$260.27 B35.75%
2016-12-31HK$191.73 B17.92%
2015-12-31HK$162.59 B0.21%
2014-12-31HK$162.26 B18.84%
2013-12-31HK$136.53 B-10.24%
2012-12-31HK$152.11 B-2.68%
2011-12-31HK$156.30 B8.05%
2010-12-31HK$144.66 B4.02%
2009-12-31HK$139.06 B-19.93%
2008-12-31HK$173.67 B66.59%
2007-12-31HK$104.25 B22.14%
2006-12-31HK$85.35 B-20.16%
2005-12-31HK$106.90 B-1.36%
2004-12-31HK$108.38 B17.27%
2003-12-31HK$92.42 B10.06%
2002-12-31HK$83.97 B15.43%
2001-12-31HK$72.75 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
HK$887.04 B 24.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$488.58 B-31.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$903.42 B 26.95%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$1.066 T 49.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$629.09 B-11.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$515.84 B-27.51%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$606.57 B-14.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$611.64 B-14.05%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$535.05 B-24.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$478.79 B-32.72%๐Ÿ‡ฌ๐Ÿ‡ง UK